Related Experiment Video
Updated: Aug 30, 2025

A Thrombotic Stroke Model Based On Transient Cerebral Hypoxia-ischemia
Published on: August 18, 2015
Stroke-Heart Syndrome: Recent Advances and Challenges
Jan F Scheitz1,2,3,4,5, Luciano A Sposato5,6,7, Jeanette Schulz-Menger8,9
1Department of Neurology With Experimental Neurology Charité-Universitätsmedizin Berlin Berlin Germany.
Ischemic stroke often leads to severe cardiac complications, termed stroke-heart syndrome. Understanding its neurocardiogenic mechanisms, involving autonomic dysfunction and inflammation, is crucial for identifying new therapeutic targets.
Area of Science:
- Cardiology
- Neurology
- Neuroscience
Background:
- Ischemic stroke frequently causes cardiovascular complications, affecting 10-20% of patients acutely.
- These complications range from myocardial injury and arrhythmias to heart failure, collectively termed stroke-heart syndrome.
- Stroke-heart syndrome encompasses neurocardiogenic mechanisms linking brain injury to cardiac events.
Purpose of the Study:
- To refine understanding of stroke-heart syndrome's clinical manifestations and pathophysiology.
- To explore the role of cerebral and systemic mediators in stroke-induced cardiac injury.
- To highlight the need for collaborative research to identify therapeutic targets.
Main Methods:
- Review of experimental and clinical studies on stroke-heart syndrome.
- Analysis of neurocardiogenic mechanisms, including autonomic dysfunction and inflammation.
- Examination of altered cardiomyocyte metabolism and immune cell dysregulation.
Main Results:
- Stroke-heart syndrome involves autonomic dysfunction, inflammation, altered cardiomyocyte metabolism, and vascular changes.
- Differentiating comorbid cardiovascular disease from stroke-induced injury remains a clinical challenge.
- New findings deepen the understanding of stroke-heart syndrome's pathophysiology.
Conclusions:
- Integrated research in cardiology and neurology is essential for advancing stroke-heart syndrome understanding.
- Identifying specific therapeutic targets requires further investigation.
- Collaborative efforts are needed to develop effective clinical trials for stroke-induced cardiac complications.
More Related Videos
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Atherosclerosis IV: Nursing Management
Acute Coronary Syndrome I: Introduction
Heart Failure I: Introduction

